Click for Full Press Release:
  Feb, 2007
  Jan 7, 2007
  Dec, 2006
  Feb 28, 2006
  Sept 06, 2005
  March 30, 2004
  May 30, 2001
  April 21, 2000
  August 1, 1998



 

In The News:

  Forbes
  Sunday Times
  Wall Street Journal
  Photonics Spectra
  Investor Business Daily
  New York Times
  San Francisco Chronicle


Email:
Info@Lumacare.com
Sales@LumaCare.com

Phone:
+1 949 644 0126

USA Address:
P.O. Box 2024,
Newport Beach, CA 92659

NEWS AND EVENTS

See LumaCare in 2008 At:

American Academy of Dermatology - 66th Annual Meeting - February 1-5, 2008
San Antonio, TX
www.aad.org/meetings
 


LumaCare will be sponsoring the 28th Annual VCS Conference in Seattle Washington, at the Westin  October 18- 21, 2008 www.vetcancersociety.org




See us at Medica  2008 in partnership with Lynton Lasers, LumaCare's UK Distributor. www.medica.de Show Dates 19 - 22 November, 2008

 


MOST CURRENT LUMACARE PRESS RELEASES:

    Jan 15, 2007 - NEW!
    LumaCare® has developed an illumination source for Photodynamic Therapy that is simple, elegant, safe and cost effective.
    ...Read More
    Jan 7, 2007 - NEW!
    LumaCare® has developed an illumination source for Photodynamic Therapy that is simple, elegant, safe and cost effective.
    ...Read More
    Feb 28, 2006
    The LumaCare® Appoints Lynton Lasers Ltd., as the official Master Distributor for European Union. Lynton Lasers currently distributes medical lasers and IPL light sources into the cosmetic, medical and aesthetic market.
    ...Read More
    Sept 06, 2005
    The LumaCare® LC-122M receives the coveted European CE Medical Device approval. Ci-Tec, Ltd., a subsidiary of MBG Technologies, Inc., today announces the LC-122M non-coherent PDT activation device has received CE Medical approval. The approvals include Protocol usage of the LC-122M to activate Photodynamic Drugs such as: ALA, 5-ALA, Foscan®, Levulan®, Metex®, Photofrin®, and others.
    ...Read More
    March 30, 2004
    Lumacare(r) announces that the LC-122M non-coherent PDT activation device has received CE Medical approval. The approval stems from the usage of the LC-122M to activate Photodynamic protocols such as: ALA, 5-ALA, Foscan®, Levulan®, Metvix®, Photofrin®, and others, "We have finally proven that a non-coherent light source can activate PDT protocols without an expensive, potentially dangerous laser."
    ...Read More

 

Website Designed and Maintained by Rod Steel Designs
© 1996-2008 MBG Technologies